This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

JMP Group Announces Addition Of Michael King As Equity Research Analyst

JMP Group Inc. (NYSE: JMP), an investment banking and alternative asset management firm, announced today that Michael G. King, Jr. has joined JMP Securities as a senior equity research analyst. Mr. King, a managing director, follows the biotechnology industry. He is based in the firm’s New York office.

“JMP Securities has one of the top life sciences franchises on Wall Street,” said Mark Lehmann, president of JMP Securities. “Mike’s arrival signifies JMP’s dedication to further expanding that platform in order to provide ever greater value to the firm’s institutional customers and corporate clients in this highly complex space. Mike is a seasoned analyst with a proven ability to generate differentiated perspectives and actionable insights as a result of a career that has included both accomplishments on the sell-side and successes within the biotech industry. He is a key addition in a key area for the firm.”

Prior to joining JMP Securities, Mr. King was a managing director at Dawson James Securities, where he served as director of research and as a senior biotechnology analyst. He was previously a managing director and senior research analyst at Rodman & Renshaw, a senior vice president and director of corporate development at publicly traded ZIOPHARM Oncology, and a managing director and senior equity analyst at Wedbush Securities. Beforehand, Mr. King served as a managing director and senior biotechnology analyst both at Merriman Curhan Ford and at Rodman & Renshaw, where, in his initial tenure with the company, he was also the director of research. Additionally, Mr. King has held senior equity research positions at Banc of America Securities, Robertson Stephens, Vector Securities and Dillon Read & Co., covering a wide range of market capitalizations and therapeutic categories and earning recognition in analyst rankings produced by The Wall Street Journal and Institutional Investor. Mr. King began his career as a biotechnology specialist in the private client sales divisions of Alex. Brown & Co., Hambrecht & Quist and Kidder, Peabody & Co. He holds a BA in finance from The Bernard M. Baruch College of the City University of New York.

About JMP Group

JMP Group Inc. is a full-service investment banking and asset management firm that provides investment banking, sales and trading, and equity research services to corporate and institutional clients as well as alternative asset management products to institutional and high-net-worth investors. JMP Group operates through three subsidiaries: JMP Securities, Harvest Capital Strategies and JMP Credit Advisors. For more information, visit www.jmpg.com.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,757.91 +138.40 0.79%
S&P 500 2,077.42 +14.31 0.69%
NASDAQ 5,013.1230 +26.2560 0.53%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs